Mefloquine has been used in tens of millions of people over several decades. World experts and bodies like the World Health Organization, the Centers for Disease Control in the United States of America, the Committee to Advise on Tropical Medicine and Travel continue to look at all the evidence that is available with respect to mefloquine and recommend it as a first-line medication to prevent malaria.
Our conclusion from the statements, the assessment of what our allies have done, is that we should continue to offer mefloquine as an antimalaria medication, particularly to those who have used it in the past and were satisfied with the medication.
It's important to make sure that we consider all the available evidence and not rely on small bits of information, small groups of scientists who have opinions and theories, or jump to conclusions that might remove what has been recommended by the world experts as a useful antimalaria medication.